raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:99879

Familial isolated hyperparathyroidism

Synonyms: FIHPT

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

A rare, hereditary, familial primary hyperparathyroidism disease characterized by primary hyperparathyroidism due to single or multiple parathyroid tumors in at least two first-degree relatives in the absence of evidence of other endocrine disorders, tumors and/or systemic manifestations.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFamilial isolated hyperparathyroidismFIHPT
frHyperparathyroïdie isolée familiale
deHyperparathyreoidismus, familiär isolierter (FIHPT)
esHiperparatiroidismo aislado familiar= en
itIperparatiroidismo isolato familiare
nlFamiliale geïsoleerde hyperparathyreoïdie= en
ptHiperparatiroidismo isolado familiar= en
plRodzinna izolowana nadczynność przytarczyc= en
csFamiliární izolovaný hyperparathyroidismus= en
ukСімейний ізольований гіперпаратиреоз= en
zh家族性孤立型甲状旁腺功能亢进= en
trailesel izole hiperparatiroidi= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM145000BTNTvalidated
OMIM600166BTNTnot yet validated
OMIM610071BTNTvalidated
OMIM617343BTNTvalidated
OMIM618883BTNTvalidated
ICD-10E21.0NTBTattributedvalidated
ICD-115A51.0NTBTindexvalidated
MONDO0015027Evalidated
MeSHC564166Evalidated
UMLSC4551961Evalidated
MedDRA10080773Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

Codes that Orphanet moved or referred to this one:

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CDC73Disease-causing germline mutation(s) inAssessedHGNC:16783ENSG000001343716073931q31.2cell division cycle 7320301744[PMID]_15531515[PMID]
GCM2Disease-causing germline mutation(s) inAssessedHGNC:4198ENSG000001248276037166p24.2GCM transcription factor 227745835[PMID]
MEN1Disease-causing germline mutation(s) inAssessedHGNC:7010ENSG0000013389561373311q13.1menin 19792884[PMID]_10664521[PMID]_12699448[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families100 familiesWorldwideFamily(ies)Validated18084346[PMID]
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET_18084346[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2016-02-10
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000934Chondrocalcinosis
HP:0003165Elevated circulating parathyroid hormone level
HP:0040160Generalized osteoporosis
HP:0003072Hypercalcemia
HP:0002150Hypercalciuria
HP:0003109Hyperphosphaturia
HP:0002148Hypophosphatemia
HP:0000121Nephrocalcinosis
HP:0000938Osteopenia
HP:0002897Parathyroid adenoma
HP:0008200Primary hyperparathyroidism
Occasional (29-5%)
HP:0011458Abdominal symptom
HP:0000083Renal insufficiency

Run the differential on the 11 obligate / very frequent terms

Annotation source: 23652676[PMID]

7

Sources for this card